Fortis Healthcare Declines 4.56%: 3 Key Factors Driving the Weekly Downtrend

35 minutes ago
share
Share Via
Fortis Healthcare Ltd experienced a challenging week from 21 to 25 September 2026, with its stock price declining 4.56% to close at ₹835.10, underperforming the Sensex which fell 0.76% over the same period. Despite an initial strong start on Monday, the stock faced persistent selling pressure amid bearish technical signals and a surge in derivatives open interest, reflecting growing market caution and speculative positioning.

Key Events This Week

21 Sep: Stock opens strong at ₹897.00 (+2.51%)

22 Sep: Technical momentum shifts to mildly bearish

24 Sep: Sharp 24.6% rise in open interest amid price decline

25 Sep: Open interest surges 44.1% as price falls 4.97%

Week Open
₹875.00
Week Close
₹835.10
-4.56%
Week High
₹897.00
vs Sensex
-3.80%

Monday, 21 September: Strong Opening Rally

Fortis Healthcare began the week on a positive note, closing at ₹897.00, a gain of 2.51% from the previous Friday’s close of ₹875.00. This outperformance contrasted with the Sensex’s modest 0.46% rise to 35,787.64. The volume was robust at 2,57,165 shares, signalling renewed investor interest. The stock’s intraday range between ₹887.05 and ₹906.45 suggested some volatility but overall bullish sentiment on the day.

Tuesday, 22 September: Technical Momentum Shifts Amid Mixed Signals

Despite the previous day’s gains, Fortis Healthcare’s technical momentum began to shift. The stock closed slightly lower at ₹894.25, down 0.31%, while the Sensex declined 0.32%. Technical indicators revealed a transition from a sideways trend to a mildly bearish stance, with weekly and monthly MACD and KST oscillators signalling weakening momentum. Daily moving averages showed mild bullishness, but the overall picture was cautious. The stock remained well below its 52-week high of ₹1,105.00, indicating room for downside risk.

Wednesday, 23 September: Continued Decline Despite Sensex Gains

Fortis Healthcare’s stock price slipped further to ₹891.00, a 0.36% decline, even as the Sensex rose 0.56% to 35,870.78. The volume dropped sharply to 11,738 shares, reflecting reduced trading activity. The stock’s technical outlook remained bearish, trading below all key moving averages. Delivery volumes also declined, suggesting waning conviction among long-term holders. This day marked the beginning of a sustained downward trend that would intensify later in the week.

Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!

  • - Rigorous evaluation cleared
  • - Expert-backed selection
  • - Mid Cap conviction pick

See Expert Backing →

Thursday, 24 September: Sharp Open Interest Surge Amid Bearish Momentum

The stock closed at ₹878.75, down 1.37%, underperforming the Sensex’s 1.62% decline. Notably, Fortis Healthcare’s open interest in derivatives surged 24.58% to 26,168 contracts, signalling heightened speculative activity despite the falling price. Futures volume was robust at 12,668 contracts, with combined futures and options value reaching approximately ₹2,276 crores. The stock traded within a narrow range, reflecting subdued volatility amid bearish sentiment. Delivery volumes dropped 20.02% to 6.19 lakh shares, indicating cautious investor participation. The stock remained below all key moving averages, reinforcing the negative technical outlook.

Friday, 25 September: Open Interest Soars 44.1% as Price Plummets

Fortis Healthcare’s stock price plunged 4.97% to ₹835.10, marking the steepest daily loss of the week and extending a three-day losing streak. The Sensex marginally rose 0.18%, highlighting the stock’s underperformance. Open interest in derivatives surged 44.12% to 30,296 contracts, with total volume at 38,261 contracts. The futures segment alone accounted for ₹57,907.88 lakhs in value, while options reflected ₹19,649.23 crores, underscoring intense derivatives market activity. Delivery volumes fell nearly 34% to 5.07 lakh shares, suggesting reduced long-term investor conviction. The stock’s sustained trading below all major moving averages signals persistent bearish momentum and heightened uncertainty.

Considering Fortis Healthcare Ltd? Wait! SwitchER has found potentially better options in and beyond. Compare this mid-cap with top-rated alternatives now!

  • - Better options discovered
  • - + beyond scope
  • - Top-rated alternatives ready

Compare & Switch Now →

Daily Price Comparison: Fortis Healthcare vs Sensex

Date Stock Price Day Change Sensex Day Change
2026-09-21 ₹897.00 +2.51% 35,787.64 +0.46%
2026-09-22 ₹894.25 -0.31% 35,672.04 -0.32%
2026-09-23 ₹891.00 -0.36% 35,870.78 +0.56%
2026-09-24 ₹878.75 -1.37% 35,291.38 -1.62%
2026-09-25 ₹835.10 -4.97% 35,353.29 +0.18%

Key Takeaways

1. Technical Momentum Shift: The week saw Fortis Healthcare’s technical indicators turn mildly bearish, with weekly and monthly MACD and KST oscillators signalling weakening momentum. The stock consistently traded below all major moving averages, indicating sustained downward pressure.

2. Derivatives Market Activity: A pronounced surge in open interest—24.6% on 24 September and 44.1% on 25 September—amid falling prices suggests increased speculative positioning and hedging activity. This divergence points to market uncertainty and potential for heightened volatility.

3. Declining Investor Participation: Delivery volumes dropped significantly during the week, reflecting reduced conviction among long-term holders and a shift towards short-term trading or hedging strategies. Despite this, liquidity remained adequate for sizeable trades.

Fortis Healthcare’s Mojo Score of 44.0, graded as Sell and downgraded from Hold on 15 September 2026, aligns with the cautious technical and market sentiment observed this week. The stock’s underperformance relative to the Sensex and hospital sector peers underscores the challenges faced amid evolving sector dynamics and regulatory pressures.

Investors should remain vigilant, monitoring open interest trends and price action closely to discern whether the current bearish momentum will persist or if a consolidation phase may emerge.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News